Skip to main content
. 2007 Jul 16;51(9):3259–3263. doi: 10.1128/AAC.00508-07

TABLE 2.

Adverse events in the two treatment groups (intention-to-treat analysis)

Adverse event No. (%) of occurrences ina:
P value
Doxycycline group Azithromycin group
All 40 (27.6) 16 (10.6) <0.001
Nausea 3 (2.1) 1 (0.7)
Vomiting 22 (15.2) 10 (5.9)
Nausea and vomiting 10 (6.9) 1 (0.7)
Diarrhea 1 (0.6) 1 (0.7)
Abdominal pain 1 (0.6) 0
Rash 1 (0.6) 3 (0.2)
Dizziness 2 (1.2) 0
a

For the doxycycline group, n = 145; for the azithromycin group, n = 151.